Resultados de procura - Hariharan Subramanian
- Mostrando 1 - 20 Resultados de 64
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
PA01.13. Hemiplegia - An ayurvedic perspective por Hariharan, Subramanian, Prasanna Kumar, T. M., Gobinath, N.
Publicado 2012Text -
6
-
7
-
8
-
9
-
10
-
11
Anti-programmed cell death-1/ligand-1 (PD-1/PD-L1) antibodies for the treatment of urothelial carcinoma: state-of-the-art and future development por Powles, Thomas, Necchi, Andrea, Rosen, Galit, Hariharan, Subramanian, Apolo, Andrea B.
Publicado 2017Text -
12
-
13
-
14
-
15
-
16
Interferometric Spectroscopy of Scattered Light Can Quantify the Statistics of Subdiffractional Refractive-Index Fluctuations por Lusik Cherkezyan, Ilker Capoglu, Hariharan Subramanian, Jeremy D. Rogers, Dhwanil Damania, Allen Taflove, Vadim Backman
Publicado 2013Artigo -
17
-
18
G protein coupled receptor specificity for C3a and compound 48/80-induced degranulation in human mast cells: Roles of Mas-related genes MrgX1 and MrgX2 por Sakeen W. Kashem, Hariharan Subramanian, Sarah J. Collington, Paola Magotti, John D. Lambris, Hydar Ali
Publicado 2011Artigo -
19
Early screening of colorectal cancer using feature engineering with artificial intelligence-enhanced analysis of nanoscale chromatin modifications por Andrew Chang, Sravya Prabhala, Ali Daneshkhah, Jianan Lin, Hariharan Subramanian, Hemant K. Roy, Vadim Backman
Publicado 2024Artigo -
20
Randomized Phase III Trial of Temsirolimus and Bevacizumab Versus Interferon Alfa and Bevacizumab in Metastatic Renal Cell Carcinoma: INTORACT Trial por Brian I. Rini, Joaquim Bellmunt, Jill S. Clancy, Kongming Wang, Andreas G. Niethammer, Hariharan Subramanian, Bernard Escudier
Publicado 2013Artigo
Ferramentas de procura:
Materias Relacionadas
Medicine
Biology
Internal medicine
Cell biology
Biochemistry
Chemistry
Oncology
Cancer
Immunology
Receptor
Genetics
Mast cell
Renal cell carcinoma
Sunitinib
Degranulation
Gastroenterology
Adverse effect
Gene
Chromatin
Immunotherapy
Signal transduction
Avelumab
Cancer research
Carcinogenesis
Chemotherapy
Clinical trial
G protein-coupled receptor
Inflammation
Carcinoma
Cell